EMA Authorised: Pemetrexed Accord (pemetrexed disodium hemipentahydrate) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Pemetrexed Accord (pemetrexed disodium hemipentahydrate) for treatment of non-small cell lung cancer and mesothelioma; marketing authorization ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed Accord (pemetrexed disodium hemipentahydrate)

Snippet

Status: Authorised. Therapeutic area: Carcinoma, Non-Small-Cell Lung;Mesothelioma. MAH: Accord Healthcare S.L.U.. Decision date: 10/07/2025